| Net Income | |
| Depreciation | 1.92M |
| Share-based compensation | 130K |
| Warrant interest expense | |
| Deferred income taxes | |
| Trade accounts receivables | -751K |
| Inventories | 1.11M |
| Other current assets | |
| Accounts payable and accrued expenses | 341K |
| Net cash provided by operating activities | |
| Additions to property, plant and equipment | -894K |
| Proceeds from sales of property, plant and equipment | |
| Net cash used in investing activities | |
| Net Proceeds from (payments on) Lines of Credit | |
| Net proceeds from export credit refinancing facility | |
| Payments on capital lease | |
| Payments on long-term bank debt | |
| Proceeds from the issuance of common stock, and exercise of common stock options | |
| Preferred stock dividends paid | |
| Net cash provided by (used in) financing activities | |
| Effect of exchange rate fluctuations on cash and cash equivalents | |
| Net decrease in cash and cash equivalents | 2.27M |
| Cash and cash equivalents at beginning of year | 813K |
| Cash and cash equivalents at end of year | 3.08M |
| Interest paid | |
| Income taxes paid | |
| Conversion of debentures | |